Kilpatrick Townsend’s Silicon Valley-based start-up team advised the founders of Editas Medicine in the biotech start-up’s $43 million Series A Financing. In a trend setting transaction, venture firms Polaris Partners, Third Rock Ventures, Flagship Ventures and the Partners Innovation Fund invited five of the most prominent research scientists in the field of genomics from MIT, Harvard, the Howard Hughes Medical Institute and the University of California in Berkeley to form a company which they would fund. The money invested will fund the collaborative research and development by this world-class team of scientists as they seek to revolutionize the treatment of genetic disorders by developing a simple, precise and inexpensive method of ‘editing out’ abnormalities in genes in human cells.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Patent litigation for major tire manufacturer
The firm served as lead counsel on behalf of automobile manufacturers in a suit in the Western District of Wisconsin. The suit alleged that the more
Advice to an independent committee of board of directors of a private company
Represented an independent committee of the board of directors of a large private company, that was formed to investigate and to decide what to do in more
Counsel regarding design and construction for an international construction company
Represent a Georgia-based, international design and construction engineering company in connection with the design and construction more
Product liability of an automotive manufacturer
Represented German automotive manufacturer in first-collision, crashworthiness, and failure-to-warn cases in courts across the country. Also defended more